NCT01556061

Brief Summary

The investigators hypothesize that the D-MAC (Dblade with C-MAC system) may be a suitable alternative device for difficult laryngoscopy and tracheal intubation in morbidly obese patients. The D-MAC will enable superior view of the glottic structures as well as easier endotracheal intubations than the C-MAC blade. This is the first study to investigate the individual and comparative performances of C-MAC and D-MAC in this patient cohort.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_4 obesity

Timeline
Completed

Started Jun 2011

Shorter than P25 for phase_4 obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 1, 2012

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 16, 2012

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

May 26, 2014

Completed
Last Updated

May 26, 2014

Status Verified

April 1, 2014

Enrollment Period

6 months

First QC Date

March 1, 2012

Results QC Date

July 27, 2013

Last Update Submit

April 25, 2014

Conditions

Keywords

LaryngoscopyAirway ManagementIntubation

Outcome Measures

Primary Outcomes (1)

  • Time for Intubation

    Time taken for successful placement of endotracheal tube after a successful laryngoscopy. Typically a successful laryngoscopy will range from few seconds to no more than 90 seconds. A successful intubation will not range more than 90 seconds.

    90 seconds

Secondary Outcomes (2)

  • First Laryngoscopy

    30 seconds

  • Second Laryngoscopy

    30 seconds

Study Arms (2)

D-MAC video laryngoscopy

EXPERIMENTAL

The Dblade is used to perfom laryngoscopy first but second laryngoscopy and intubation is performed with CMAC blade.

Device: DMACDevice: CMAC

C-MAC video laryngoscopy

ACTIVE COMPARATOR

The CMAC blade is used to perfom laryngoscopy first but second laryngoscopy and intubation is performed with D-blade

Device: DMACDevice: CMAC

Interventions

DMACDEVICE

The D blade will constitute the experimental treatment and in a cross over fashion will be tested against CMAC blade

Also known as: D-Blade CMAC system
C-MAC video laryngoscopyD-MAC video laryngoscopy
CMACDEVICE

The CMAC Blade will constitute the active comparator treatment and in a cross over fashion will be tested against D-blade

Also known as: CMAC blade
C-MAC video laryngoscopyD-MAC video laryngoscopy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65 years
  • ASA I-III
  • BMI ≥ 40 kg/m2

You may not qualify if:

  • Necessary awake intubation
  • Mallampati IV
  • \< 2 finger breath or 4 cm mouth opening
  • Previous history of difficult intubation
  • ASA IV-V
  • Unstable cervical, thoracic and/or lumbar fracture
  • Known history of congestive heart failure or a severe disease that alters pulmonary mechanics (e.g. chronic obstructive pulmonary disease, restrictive lung diseases)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Memorial Hermann Hospital-TMC

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Davide Cattano MD PhD
Organization
University of Texas at Houston Medical School/ Dept. of Anesthesiology

Study Officials

  • Davide Cattano, MD, PhD

    University Of Texas at Houston Medical School

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 1, 2012

First Posted

March 16, 2012

Study Start

June 1, 2011

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

May 26, 2014

Results First Posted

May 26, 2014

Record last verified: 2014-04

Locations